CardioVascular BioTherapeutics (fka CVBT)

[heartdr]

WOW!!



Thank you, johnnymcgriffin347. Your praise is gratefully accepted.

"Only mention patents." You obviously didn't read the statement by the Chairman of Novo Nordisk. Let me help you by reposting it for you.
"Anyone, I would imagine, who has tried to create a biotech company knows just how important patents are. You learn this when you’re studying, and again at your first job, and if you haven’t done so before, you realize it the first time you meet potential investors. (Mads Øvlisen, Chairman of the Board of Directors, Novo Nordisk)."

Patents at the Core: the Biotech Business

Major investment banks & institutional shareholders base a large part of the value of biotech companies in their patent portfolio.
Just to remind you VT has 7 patents, 31 pending in a $139bn marketplace. WOW!!